Genital Herpes Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
- Healthcare IT
Sexually transmitted diseases (STD) are also known as venereal diseases, are generally caused by infections that are transmitted from one person to the other during sexual intercourse. Sexually transmitted infections (STI) are caused by more than 30 different viruses, bacteria, and parasites. Common type of STDs include chlamydia, gonorrhea, syphilis, genital herpes, and trichomoniasis. Genital herpes is a STI caused by herpes simplex virus. Blisters on or around genitals, vaginal discharge, pelvic pain, and penile discharge are some common symptoms of genital herpes. As stated by the World Health Organization (WHO) in December 2015, around 1 million sexually transmitted infections are developed every day, globally. As per WHO, in the U.S. around 15% of people with herpes simplex virus infection report prior diagnosis of genital herpes. Accurate diagnostic tests such as competitive polymerase chain reactions (PCR), DNA enzyme immunoassay hybridization, real-time PCR assay are extensively used to diagnose STIs in developed countries. These tests are useful for the diagnosis of asymptomatic infections. These diagnostic tests are very expensive, the only inexpensive, rapid tests currently available for STIs are for syphilis and HIV.
Increase in demand for effective therapeutic options for the treatment of these infections is expected to drive the genital herpes treatment market during forecasting period. In order to address the urgent need of better treatment for sexually transmitted infections and to combat rapid development of antiviral-resistant species, governments across the world have taken initiatives which would support the growth of genital herpes treatment market. The Innovative Medicine Initiative (IMI) in partnership with the European Union and the pharmaceutical industry in Europe aims at developing innovative therapeutic alternatives to create new opportunities for STD treatment. This, in turn, is projected to support the expansion of the genital herpes treatment market.
The global genital herpes treatment market has been segmented based on type of drugs, distribution channel, and geography. In general antiviral therapy is prescribed in line to treat genital herpes. Based on type of drugs, the genital herpes treatment market has been divided into acyclovir, famciclovir, valacyclovir, and others. Acyclovir is commonly used as first line antiviral agent and is expected to hold a significant share of the market during the forecast period. There are few antivirals such as valacyclovir used in herpes infection also used to treat genital herpes. Based on distribution channels, the genital herpes treatment market has been divided into hospitals, retail pharmacy, and online pharmacy. Retail pharmacy accounted for a considerable share of the market due to presence of generic market. The online pharmacy segment is expected to expand in the near future due to the rise in adoption of online purchases in developed countries such as the U.S.
In terms of geography, the global genital herpes treatment market has been categorized into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America dominated the global genital herpes treatment market. The region is expected to be a highly attractive market for STD drugs during the forecast period. Dominance of the region can be attributed to the rising prevalence of the disease and high cost of drugs. North America and Europe are expected to remain the prominent markets due to high consumption of antiviral drugs. The market in Asia Pacific and Latin America is expected to expand in later stage of forecast period due to rising awareness regarding treatments for genital herpes.
Key players operating in the genital herpes treatment market are GlaxoSmithKline, Teva Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Apotheca Inc., Sandoz Inc., Novartis AG, Hospira Inc., Novopharm Ltd., and Dr. Reddy’s Laboratories Ltd.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare IT
Healthcare ITGlobal mHealth Market Research Report 2016
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017